ADAM10 and Alzheimer disease: While these in vivo effects, including improved object recognition in transgenic AD model mice (Rat et al., 2011), appear favorable for treatment, Gardoni et al reported that PACAP treatment of primary hippocampal neurons led to postsynaptic ADAM10 accumulation and N-cadherin-dependent reductions in spine head volume and reduced postsynaptic GluR1 expression (Gardoni et al., 2012).